Lurasidone hydrochloride intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |
(1R,2R)-(-)-trans-cyclohexane-1,2-dicarboxylic acid | 46022-05-3 | C8H12O4 | ![]() |
≥98.5% | Used to synthesize lurasidone hydrochloride | |
(1R,2R)-1,2-Cyclohexanedimethanol | 65376-05-8 | C8H16O2 | ![]() |
≥98.5% | Used to synthesize lurasidone hydrochloride | |
(1R,2R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane | 186204-35-3 | C10H20O6S2 | ![]() |
≥98.5% | Used to synthesize lurasidone hydrochloride | |
(3aR,4S,7R,7aS)-4,7-Methano-1H-isoindole-1,3(2H)-dione | 14805-29-9 | C9H11NO2 | ![]() |
≥98.5% | Used to synthesize lurasidone hydrochloride | |
4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl]piperazin-1-ium-1-sulfonate | 186204-37-5 | C19H26N4O3S2 | ![]() |
≥98.5% | Used to synthesize lurasidone hydrochloride | |
(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride | 2746-19-2 | C9H8O3 | ![]() |
≥98.5% | 2932999099 | Used to synthesize lurasidone hydrochloride |
3-(1-Piperazinyl)-1,2-benzisothiazole | 87691-87-0 | C11H13N3S | ![]() |
≥98.5% | 2934200090 | Used to synthesize lurasidone hydrochloride |
1,2-Cyclohexanedicarboxylic acid | 2305-32-0 | C8H10O4 | ![]() |
≥95% | 2917209090 | Used to synthesize lurasidone hydrochloride |
Indole series intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |
2-methylindole | 95-20-5 | C9H9N | ![]() |
≥99% | 2933990090 | Pharmaceutical intermediates, dye intermediates and fixatives in the perfume industry. |
1-amino-2-methylindoline hydrochloride | 102789-79-7 | C9H13ClN2 | ![]() |
≥99% | 2933990099 | Used to synthesize indapamide |
Isosorbide mononitrate intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |
Isosorbide | 652-67-5 | C6H10O4 | ![]() |
≥99% | It can be used to treat cerebral edema and glaucoma; It can be used to synthesize isosorbide dinitrate and isosorbide mononitrate; |
Pomalidomide intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |
3-Amino-2,6-piperidinedione hydrochloride | 24666-56-6 | C5H8N2O2·HCl | ![]() |
≥98%;≥99% | Used in the synthesis of pomalidomide, also known as intermediate 2 |
Gliclazide intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |
tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione | 5763-44-0 | C7H9NO2 | ![]() |
≥99% | For the synthesis of gliclazide | |
Loxoprofen sodium intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |
2-(4-Bromomethyl)phenylpropionic acid | 111128-12-2 | C10H11BrO2 | ![]() |
≥99% | 2916399090 | Used to synthesize loxoprofen |
Tadalafil intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |
Lipoic acid intermediate | ||||||
Product Name | CAS NO. | Molecular formula | Structural formula | QS | Customs code | Application |